DOTAREM
Drug
GUERBET LLC
Total Payments
$753,231
Transactions
287
Doctors
99
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $10,215 | 1 | 1 |
| 2022 | $13,872 | 16 | 3 |
| 2021 | $338,281 | 6 | 0 |
| 2017 | $390,863 | 264 | 96 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $544,785 | 26 | 72.3% |
| Honoraria | $111,862 | 39 | 14.9% |
| Travel and Lodging | $47,558 | 75 | 6.3% |
| Consulting Fee | $23,991 | 6 | 3.2% |
| Food and Beverage | $13,451 | 137 | 1.8% |
| Grant | $6,710 | 3 | 0.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,875 | 1 | 0.6% |
Payments by Type
Research
$544,785
26 transactions
General
$208,446
261 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Contrast Enhanced Breast MRI: Comparison of Two Macrocyclic Gadolinium-Based Contrast Agents: Gadoterate Meglumine (Dotarem) and Gadobutrol (Gadavist). A Prospective Study. | GUERBET LLC | $115,254 | 0 |
| Efficacy of Gadoterate Meglumine in Diagnosis of Vascular Diseases Using MRA | GUERBET LLC | $88,800 | 0 |
| Comparison of Diagnostic Performance of Native Non-Contrast T1 Mapping versus Dotarem Contrast Enhanced CMR for the Diagnosis of Chronic Myocardial Infarction (MI) | GUERBET LLC | $79,864 | 0 |
| Dotarem for Myocardial Perfusion CMR | GUERBET LLC | $68,083 | 0 |
| Safety and efficacy of Dotarem (Gd-DOTA) versus Magnevist (Gd-DTPA) in cardiac magnetic resonance | GUERBET LLC | $41,925 | 0 |
| Intra-individual open-label, single center study to compare unenhanced MRI with Dotarem enhanced MRI in pediatric and neonatal patient population (<18years) | GUERBET LLC | $27,675 | 0 |
| DCE-MRI for quantification of disease activity and vascular changes in ileocolic Crohns disease | GUERBET LLC | $27,486 | 0 |
| Multiparametric MRI for assessment of renal transplant dysfunction | GUERBET LLC | $27,216 | 0 |
| Observational Study on the incidence of NSF in renal impaired patients following Dotarem administration | GUERBET LLC | $20,900 | 0 |
| Gadolinium Retention in Human Bone and Tissue in Pediatric Patients: A Comparison of Dotarem Versus MultiHance MRI Contrast Agents | GUERBET LLC | $18,295 | 0 |
| Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years (ODYSSEY) | GUERBET LLC | $12,743 | 0 |
| Gadolinium Retention in Human Bone and Brain Tissue in Pediatric Patients: A Comparison of Dotarem Versus Magnevist MRI Contrast Agents | GUERBET LLC | $11,113 | 0 |
| Delayed Enhanced MRI of the heart using gadoterate meglumine | GUERBET LLC | $5,431 | 0 |
Top Doctors Receiving Payments for DOTAREM
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Houston, TX | $551,495 | 29 |
| , MD | Diagnostic Radiology | Charleston, SC | $37,081 | 27 |
| , M.D | Diagnostic Radiology | New York, NY | $21,440 | 13 |
| Kenneth Maravilla | Diagnostic Radiology | Seattle, WA | $20,562 | 12 |
| , MD, PHD | Diagnostic Radiology | Aurora, CO | $10,215 | 1 |
| , MD | Diagnostic Radiology | Ann Arbor, MI | $9,253 | 7 |
| , MD | Neurology | Brookline, MA | $6,900 | 6 |
| , MD | Diagnostic Radiology | East Rockaway, NY | $6,780 | 2 |
| , M.D | Pediatric Cardiology | Philadelphia, PA | $6,754 | 2 |
| , M.D | Neuroradiology | Los Angeles, CA | $4,377 | 6 |
| , M.D | Neuroradiology | Saginaw, MI | $3,370 | 6 |
| , M.D | Pediatric Radiology | Houston, TX | $3,330 | 6 |
| , M.D | Neurology | Los Angeles, CA | $3,259 | 6 |
| , MD | Pediatric Radiology | Charleston, SC | $3,234 | 6 |
| , MD | Neuroradiology | East Lansing, MI | $3,219 | 6 |
| , MD | Diagnostic Radiology | Los Angeles, CA | $3,026 | 4 |
| , MD | Anatomic Pathology | Syracuse, NY | $3,009 | 4 |
| , M.D | Diagnostic Radiology | Durham, NC | $2,802 | 3 |
| , M.D | Diagnostic Radiology | Chicago, IL | $2,785 | 4 |
| , MD | Diagnostic Radiology | Scottsdale, AZ | $2,746 | 3 |
| , MD | Diagnostic Radiology | Saint Louis, MO | $2,737 | 5 |
| , M.D | Diagnostic Radiology | Chicago, IL | $2,691 | 5 |
| , M.D | Diagnostic Radiology | Shreveport, LA | $2,671 | 5 |
| Reena Jha | Body Imaging | Washington, DC | $2,657 | 6 |
| , MD | Diagnostic Radiology | Grayslake, IL | $2,641 | 5 |
Ad
Manufacturing Companies
- GUERBET LLC $753,231
Product Information
- Type Drug
- Total Payments $753,231
- Total Doctors 99
- Transactions 287
About DOTAREM
DOTAREM is a drug associated with $753,231 in payments to 99 healthcare providers, recorded across 287 transactions in the CMS Open Payments database. The primary manufacturer is GUERBET LLC.
Payment data is available from 2017 to 2023. In 2023, $10,215 was paid across 1 transactions to 1 doctors.
The most common payment nature for DOTAREM is "Unspecified" ($544,785, 72.3% of total).
DOTAREM is associated with 13 research studies, including "Contrast Enhanced Breast MRI: Comparison of Two Macrocyclic Gadolinium-Based Contrast Agents: Gadoterate Meglumine (Dotarem) and Gadobutrol (Gadavist). A Prospective Study." ($115,254).